Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis (HAART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01614405
Recruitment Status : Completed
First Posted : June 7, 2012
Last Update Posted : December 2, 2015
Gilead Sciences
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Andrew L. Mason, University of Alberta

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2015
  Actual Study Completion Date : August 2015